• NSAIDs
  • Notable elevations of ALT or AST approximately three or more times the upper limit of normal have been reported in approximately 1% of patients in clinical trials with NSAIDs. (karge.info)
  • To determine whether race is a predictor of a patient's likelihood of being prescribed selective cyclooxygenase-2 inhibitors (COX-2s) versus other nonsteroidal anti-inflammatory agents (NSAIDs) in Medicaid managed care plans (MCO). (wiley.com)